Single Dose of Psilocybin for Depression Shows Promising Results in UK's First Publicly Funded Randomized Trial

Psychedelic in magic mushrooms can ease depression

Single dose of psilocybin for depression shows promising results in UK's first publicly funded randomized trial

The first randomized controlled trial in the U.K. has found that a single dose of psilocybin, the active compound found in "magic mushrooms," produced significant improvements in depression compared with a placebo. This is the first publicly funded randomized trial of its kind to deliver the treatment within an NHS setting in England, and it found promising results.

Psychedelic in magic mushrooms can ease depression resistant to other treatments

The King's College London medical trial discovered that people who suffered from treatment resistant depression saw marked improvement in their symptoms after taking psilocybin

Magic mushrooms can ease depression resistant to other treatments, major study finds

It was the first publicly-funded trial of the therapy